Avidbank (AVBH) Expected to Post Quarterly Earnings on Thursday

Avidbank (NASDAQ:AVBH) is expected to issue its Q2 2026 results after the market closes on Thursday, July 23rd. Analysts expect Avidbank to post earnings of $0.83 per share and revenue of $28.6130 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Friday, July 24, 2026 at 11:00 AM ET.

Avidbank (NASDAQ:AVBH) last announced its quarterly earnings results on Monday, April 27th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. The firm had revenue of $27.97 million during the quarter, compared to analysts’ expectations of $28.10 million. Avidbank had a negative net margin of 10.20% and a positive return on equity of 10.88%. On average, analysts expect Avidbank to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Avidbank Price Performance

Shares of NASDAQ:AVBH opened at $32.16 on Thursday. The firm has a market cap of $352.15 million, a PE ratio of -17.11 and a beta of 0.33. The firm’s fifty day moving average is $31.35 and its 200-day moving average is $29.52. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.03 and a current ratio of 1.03. Avidbank has a 52 week low of $21.25 and a 52 week high of $34.17.

Wall Street Analysts Forecast Growth

AVBH has been the subject of several analyst reports. Wall Street Zen raised Avidbank from a “hold” rating to a “buy” rating in a research report on Saturday, May 23rd. Weiss Ratings raised Avidbank from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, April 22nd. Piper Sandler lowered their price objective on Avidbank from $37.00 to $35.00 and set an “overweight” rating for the company in a research report on Thursday, April 2nd. Finally, DA Davidson lifted their price objective on Avidbank from $33.00 to $36.00 and gave the stock a “buy” rating in a research note on Wednesday, April 29th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Avidbank presently has an average rating of “Moderate Buy” and a consensus target price of $35.33.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC bought a new stake in shares of Avidbank during the 4th quarter valued at about $677,000. Bridgeway Capital Management LLC bought a new stake in Avidbank in the fourth quarter worth approximately $332,000. Adage Capital Partners GP L.L.C. lifted its stake in Avidbank by 15.8% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 220,315 shares of the company’s stock valued at $5,852,000 after buying an additional 30,000 shares during the period. ExodusPoint Capital Management LP acquired a new position in Avidbank in the fourth quarter valued at approximately $256,000. Finally, Barclays PLC bought a new position in shares of Avidbank during the 4th quarter worth approximately $123,000. 15.87% of the stock is owned by institutional investors and hedge funds.

About Avidbank

Avidbank Holdings, Inc operates as a bank holding company for Avidbank that provides financial products and services to small and middle-market businesses, professionals, and individuals in the Santa Clara, San Mateo, and San Francisco counties. It offers business and personal deposit products, such as checking, money market, and savings accounts; and certificates of deposit. The company also provides personal lending products include secured and unsecured lines of credit, home equity lines of credit, remodel and new home construction loans, and term loans; corporate banking comprises working capital lines of credit, equipment loans, acquisition financing, shareholder buyouts, ESOP loans, and owner-occupied real estate loans; and commercial real estate lending, such as permanent loans and bridge financing products.